Fox Run Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.29M Buy
2024
Q4
$327K Buy
2023
Q2
Sell
2023
Q1
$254K Buy